| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Reviews |
1 Lankenau Institute for Medical Research, Wynnewood, Pennsylvania and 2 Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania
Requests for reprints: Janet A. Sawicki, Lankenau Institute for Medical Research, 100 Lancaster Avenue, Wynnewood, PA 19096. Phone: 610-645-3123; Fax: 610-645-2205; E-mail: sawickij{at}mlhs.org.
Key Words: fetal microchimerism cancer stem cells cancer stem cells
The persistence of fetal stem cells with multilineage potential in women who have been pregnant, a phenomenon known as fetal microchimerism, is emerging as a potential contributing factor in certain diseases, including cancer. For example, fetal microchimerism has been implicated in autoimmune disease, wound healing, and cancer. Studies of this phenomenon may provide a novel perspective on cancer in women, including in breast, ovarian, and lung cancers. [Cancer Res 2008;68(23):9567–9]
This article has been cited by other articles:
![]() |
G. C. Prendergast Stem Cells as Critical Contributors to the Tumor Microenvironment Cancer Reviews Online Content, March 1, 2009; 2009(3): 5 - 5. [Full Text] [PDF] |
||||
![]() |
G. C. Prendergast New Ideas in Cancer Etiology and Therapy: Fetal Microchimerism and Eradication of Tumor Stroma Cancer Reviews Online Content, January 1, 2009; 2009(1): 1 - 1. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |